| Title |
Macrolides versus placebo for chronic asthma
|
|---|---|
| Published in |
Cochrane database of systematic reviews, November 2021
|
| DOI | 10.1002/14651858.cd002997.pub5 |
| Pubmed ID | |
| Authors |
Krishna Undela, Lucy Goldsmith, Kayleigh M Kew, Giovanni Ferrara |
Twitter Demographics
The data shown below were collected from the profiles of 62 tweeters who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 10 | 16% |
| United Kingdom | 4 | 6% |
| Argentina | 4 | 6% |
| Brazil | 3 | 5% |
| United States | 2 | 3% |
| Malaysia | 2 | 3% |
| Canada | 2 | 3% |
| Chile | 1 | 2% |
| Colombia | 1 | 2% |
| Other | 4 | 6% |
| Unknown | 29 | 47% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 44 | 71% |
| Practitioners (doctors, other healthcare professionals) | 13 | 21% |
| Scientists | 4 | 6% |
| Science communicators (journalists, bloggers, editors) | 1 | 2% |
Mendeley readers
The data shown below were compiled from readership statistics for 85 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 85 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 11 | 13% |
| Student > Master | 8 | 9% |
| Other | 6 | 7% |
| Student > Ph. D. Student | 4 | 5% |
| Student > Doctoral Student | 3 | 4% |
| Other | 10 | 12% |
| Unknown | 43 | 51% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 18 | 21% |
| Nursing and Health Professions | 4 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 2% |
| Unspecified | 2 | 2% |
| Psychology | 2 | 2% |
| Other | 7 | 8% |
| Unknown | 50 | 59% |
Attention Score in Context
This research output has an Altmetric Attention Score of 43. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 March 2023.
All research outputs
#904,269
of 24,373,273 outputs
Outputs from Cochrane database of systematic reviews
#1,866
of 12,904 outputs
Outputs of similar age
#22,166
of 510,310 outputs
Outputs of similar age from Cochrane database of systematic reviews
#29
of 170 outputs
Altmetric has tracked 24,373,273 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,904 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 34.2. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 510,310 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 170 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 83% of its contemporaries.